EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104. A total of 123 filers reported holding EIDOS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $90,385,000 | +160.4% | 686,922 | 0.0% | 0.97% | +91.3% |
| Q3 2020 | $34,710,000 | +15.3% | 686,922 | 0.0% | 0.51% | +3.9% |
| Q2 2020 | $30,115,000 | -10.5% | 686,922 | 0.0% | 0.49% | -44.3% |
| Q1 2020 | $33,652,000 | -15.9% | 686,922 | -1.5% | 0.88% | +10.2% |
| Q4 2019 | $40,030,000 | +62.0% | 697,524 | +1.5% | 0.80% | +19.4% |
| Q3 2019 | $24,711,000 | +15.7% | 686,992 | 0.0% | 0.67% | +35.9% |
| Q2 2019 | $21,349,000 | +32.5% | 686,992 | 0.0% | 0.49% | +7.7% |
| Q1 2019 | $16,109,000 | +70.4% | 686,992 | +0.0% | 0.46% | +26.4% |
| Q4 2018 | $9,452,000 | +37.9% | 686,922 | 0.0% | 0.36% | +96.7% |
| Q3 2018 | $6,855,000 | -50.9% | 686,922 | 0.0% | 0.18% | -50.0% |
| Q2 2018 | $13,971,000 | – | 686,922 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,123,630 | $64,485,000 | 24.71% |
| RA Capital Management | 2,162,671 | $124,116,000 | 3.76% |
| Opaleye Management Inc. | 315,550 | $18,109,000 | 3.55% |
| Parkman Healthcare Partners LLC | 207,271 | $11,895,000 | 3.43% |
| Board of Trustees of The Leland Stanford Junior University | 265,670 | $15,247,000 | 1.85% |
| Cormorant Asset Management, LP | 495,692 | $28,448,000 | 1.14% |
| Redmile Group, LLC | 701,178 | $40,241,000 | 0.96% |
| Ikarian Capital, LLC | 100,000 | $5,739,000 | 0.93% |
| Perceptive Advisors | 697,524 | $40,030,000 | 0.80% |
| EAM Global Investors LLC | 33,680 | $1,933,000 | 0.77% |